AB
KYNB

Amalgamated Bank’s Kyntra Bio KYNB Stock Holding History

Amalgamated Bank’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-120
Closed -$7K – 3050
2024
Q1 		$7K Sell
120
-194
-62% -$8.36K ﹤0.01% 2576
2023
Q4 		$7K Sell
314
-36
-10% -$543 ﹤0.01% 2908
2023
Q3 		$8K Hold
350
– – ﹤0.01% 2929
2023
Q2 		$24K Sell
350
-132
-27% -$54.6K ﹤0.01% 2644
2023
Q1 		$225K Sell
482
-63
-12% -$33.3K ﹤0.01% 1756
2022
Q4 		$218K Hold
545
– – ﹤0.01% 1828
2022
Q3 		$177K Buy
545
+8
+1% +$2.58K ﹤0.01% 1897
2022
Q2 		$142K Sell
537
-12
-2% -$3.07K ﹤0.01% 2026
2022
Q1 		$165K Sell
549
-45
-8% -$15.7K ﹤0.01% 2014
2021
Q4 		$210K Sell
594
-12
-2% -$3.74K ﹤0.01% 1960
2021
Q3 		$155K Sell
606
-30
-5% -$10.6K ﹤0.01% 2032
2021
Q2 		$424K Buy
636
+183
+40% +$105K ﹤0.01% 1720
2021
Q1 		$393K Sell
453
-40
-8% -$42.6K 0.01% 1111
2020
Q4 		$457K Buy
493
+2
+0.4% +$2.1K 0.02% 1018
2020
Q3 		$504K Sell
491
-6
-1% -$6.46K 0.02% 828
2020
Q2 		$504K Sell
497
-58
-10% -$53.9K 0.02% 828
2020
Q1 		$482K Sell
555
-19
-3% -$18.9K 0.01% 930
2019
Q4 		$615K Buy
574
+33
+6% +$33.7K 0.01% 1015
2019
Q3 		$500K Sell
541
-7
-1% -$7.69K 0.01% 1036
2019
Q2 		$619K Buy
548
+91
+20% +$99.6K 0.01% 968
2019
Q1 		$621K Buy
457
+19
+4% +$25.8K 0.02% 902
2018
Q4 		$507K Buy
438
+263
+150% +$296K 0.01% 912
2018
Q3 		$266K Sell
175
-282
-62% -$434K 0.01% 1183
2018
Q2 		$715K Buy
457
+85
+23% +$111K 0.02% 866
2018
Q1 		$430K Sell
372
-8
-2% -$10.5K 0.01% 1038
2017
Q4 		$450K Buy
380
+43
+13% +$53.9K 0.01% 1038
2017
Q3 		$453K Buy
337
+44
+15% +$46.4K 0.01% 993
2017
Q2 		$237K Buy
+293
New +$204K 0.01% 1333

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Amalgamated Bank's KYNB Position: Q2 2024 in Review

Amalgamated Bank sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 120 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in KYNB in Q2 2017 and held it in 28 quarters. The position peaked at $715K in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Amalgamated Bank reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 120 Kyntra Bio shares in Q2 2024, an estimated $7K.
  • Amalgamated Bank first reported a position in Kyntra Bio in Q2 2017 and held it in 28 quarters.
  • Amalgamated Bank's Kyntra Bio position peaked at $715K in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.